CMB 11.4% 35.0¢ cambium bio limited

Article from Japan Chemical Daily. "Regeneus has already...

  1. 5,132 Posts.
    lightbulb Created with Sketch. 44
    Article from Japan Chemical Daily.

    "Regeneus has already commenced and continues preparation for further PMDA consultations for their Japan phase II clinical trial.  They have also further progressed manufacturing preparation for this trial through commencing donor selection and manufacturing process development.  AGC will be responsible for the GMP production of Progenza for the Japan clinical trial."


    http://regeneus.com.au/media/news/JapanChemicalDailyArticle.pdf
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.045(11.4%)
Mkt cap ! $4.175M
Open High Low Value Volume
39.0¢ 39.0¢ 35.0¢ $46 127

Buyers (Bids)

No. Vol. Price($)
1 75 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 13.58pm 09/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.